Pipeline update: Catch up on recent breakthroughs in retinal therapies

The retina field continues to see significant developments in the FDA pipeline, with clinical trials advancing and receiving designations that may lead to approvals for treatments in wet and dry age-related macular degeneration (AMD), geographic atrophy (GA), diabetic macular edema (DME), and other retinal diseases.